USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
PHFR, INC.
Address:
PHFR, INC.
ABBOTT BUILDING, Suite 206
PITTSBURGH, PA
Phone:
N/A
URL:
N/A
EIN:
201241624
DUNS:
602425949
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $472,591.00 2
SBIR Phase II $803,176.00 1
STTR Phase I $100,370.00 1

Award List:

Biomarker for Cognitive Impairment in Chronic Alcoholism

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$109,759.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Previous work has identified a subgroup of chronic alcoholism subjects with severe, generalized cognitive impairment and a very poor outcome. What is critically lacking are brain molecular biomarkers that antedate both the cognitive impairment and the earliest,… More

Biomarker for Cognitive Impairment in Chronic Schizophrenia

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$362,832.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This application focuses on developing a novel brain molecular biomarker for cognitive impairment in chronic schizophrenia. Previous work has suggested a subgroup of chronic schizophrenia with severe, generalized cogni tive impairment, a very poor outcome,… More

Biomarker for Cognitive Impairment in Chronic Alcoholism

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$803,176.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Previous work has identified a subgroup of chronic alcoholism subjects with severe, generalized cognitive impairment and a very poor outcome. What is critically lacking are brain molecular biomarkers that antedate both the cognitive impairment and the earliest,… More